A Phase II Trial Tetrathiomolybdate (TM), a Copper Depleting Compound, and Its Effect on Circulating Endothelial Progenitor Cells (EPCs) in Patients with Breast Cancer (BC) at High Risk of Recurrence.
2009 ◽
2012 ◽
2012 ◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. 1054-1054
2010 ◽
2007 ◽
Vol 107
(1)
◽
pp. 133-138
◽
2015 ◽
Vol 65
(10)
◽
pp. A1650